Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

The frequency of anti-infliximab antibodies in patients with rheumatoid arthritis treated in routine care and the associations with adverse drug reactions and treatment failure

Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
To investigate the frequency of anti-infliximab antibodies in patients with RA and the associations with adverse drug reactions and treatment failure.
Original languageEnglish
JournalRheumatology (Oxford, England)
Volume52
Issue number7
Pages (from-to)1245-53
Number of pages9
ISSN1462-0324
DOIs
Publication statusPublished - Jul 2013

    Research areas

  • Adult, Aged, Aged, 80 and over, Antibodies, Anti-Idiotypic, Antibodies, Monoclonal, Antirheumatic Agents, Arthritis, Rheumatoid, Female, Follow-Up Studies, Humans, Male, Middle Aged, Radioimmunoassay, Registries, Risk Factors, Treatment Failure, Treatment Refusal, Young Adult

ID: 39031827